| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT01976091 | A Gene Transfer Therapy Study to Evaluate the Safety of SRP-9004 (Patidistrogene Bexoparvovec) in Participants With Limb-Girdle Muscular Dystrophy, Type 2D (LGMD2D) | PHASE1 | COMPLETED | 6 | — | — | Feb 1, 2015 | Mar 14, 2019 | Jun 15, 2023 | - | — |
An AE is defined as any untoward medical occurrence associated with the use of a drug in humans, whether or not considered study drug related. An AE was considered serious if, in the view of the investigator or sponsor, it resulted in any of the following outcomes: death, a life-threatening AE, inpatient hospitalization or prolongation of existing hospitalization, a persistent or significant incapacity or substantial disruption of the ability to conduct normal life functions, or a congenital anomaly/birth defect. Treatment-related Treatment Emergent Adverse Event (TEAE) is defined as an TEAE that was classified by the investigator as related to treatment.
| Arm | Type | Description |
|---|---|---|
| Cohort 1A: SRP-9004 Low Dose (Single Limb Perfusion) | EXPERIMENTAL | Non-ambulant participants with LGMD2D will receive 1 low dose of SRP-9004 via ILI to a single limb on Day 0. |
| Cohort 1B Low Dose (Bilateral Limb Perfusion) | EXPERIMENTAL | Participants with LGMD2D will receive 1 low dose of SRP-9004 via ILI to both limbs on Day 0. |
| Cohort 2 High Dose (Bilateral Limb Perfusion) | EXPERIMENTAL | Participants with LGMD2D will receive 1 high dose of SRP-9004 via ILI to both limbs on Day 0. |
| Name | Type | Description |
|---|---|---|
| SRP-9004 | GENETIC | Isolated Limb Infusion (ILI) |
Key Inclusion Criteria: * Cohort 1A must be adult and wheelchair-dependent; Cohorts 1B and 2 will be participants of age 7 or older. * Confirmed alpha-sarcoglycan deficiency or identified sarcoglycan alpha (SGCA) deoxyribonucleic acid (DNA) mutation. * Participants enrolled in Cohorts 1B or 2 must ...